Affimed N.V. financial data

Symbol
AFMD on Nasdaq
Location
Gottlieb Daimler Strasse 2, Mannheim, Germany
State of incorporation
Germany
Fiscal year end
December 31
Former names
Affimed Therapeutics B.V. (to 9/16/2014)
Latest financial report
Q2 2023 - Aug 10, 2023

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 149M shares +21%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense 25.3M EUR +21.3%
General And Administrative Expense 6.28M EUR -25.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets 135M EUR -48.4%